Nivalon Medical
A medical technology company developing the world's first patient-specific, motion-preserving, metal-free spinal implants using AI-driven design and advanced ceramic 3D printing.
- CEO / Founder
- Todd Hodrinsky
- Team Size
- 1-10
- Stage
- Active
- Total Funding
- $1M
- Latest Round
- Grant
- Key Investors
- Youngstown Business Incubator (YBI)
Technology & Products
Key Products
["EvoFlex™ Patient-Specific Ceramic Spinal Implants","AI-Driven Anatomical Modeling & Design Software","Motion-Preserving Intervertebral Solutions","3D-Printed Zirconia-Toughened Alumina (ZTA) Ceramic Implants with Flexible Elastomeric Core"]
Technological Advantage
Leverages proprietary AI to translate patient CT scans into custom geometry and utilizes XJet NanoParticle Jetting technology to print zirconia-toughened alumina (ZTA) ceramic that mimics bone density, eliminates metal sensitivity, and incorporates a flexible elastomeric core to preserve natural spinal motion.
Differentiation
Value Proposition
Eliminates the 'one-size-fits-all' limitation of traditional implants by using AI to match a patient's unique anatomy, restoring natural biomechanics and reducing the risks of metal sensitivity and adjacent segment disease.
How They Differentiate
Nivalon differentiates by offering the world's first fully patient-specific, metal-free, motion-preserving spinal implants. Unlike competitors like Carlsmed who use AI for patient-specific titanium implants, Nivalon utilizes AI-driven design paired with XJet NanoParticle Jetting to create zirconia-toughened alumina (ZTA) ceramic implants with a flexible elastomeric core that mimics natural spinal motion.
Market & Competition
Target Customers
Orthopedic surgeons, neurosurgeons, specialized spine centers, and hospitals seeking advanced alternatives to traditional metal fusion hardware.
Industry Verticals
["Medical Devices","Healthcare / Spinal Surgery","Additive Manufacturing (3D Printing)","Biotechnology"]
Competitors
Carlsmed; Medtronic; NuVasive (Globus Medical)
Growth & Milestones
Growth Metrics
Produced world's first fully patient-specific, motion-preserving, metal-free spinal implant in January 2026; completed extensive independent pre-clinical validation at University of South Florida and University of Connecticut; preparing for NIH Phase II SBIR funding and FDA PMA clinical trials.
Major Milestones
["Secured U.S. Patent US-12011336-B2 for 'Patient-specific spinal implants' in June 2024","Named a finalist and winner at the Youngstown Business Incubator (YBI) Shark Tank in 2025","Produced the world's first fully patient-specific, motion-preserving, metal-free spinal implant in January 2026","First-in-human procedures planned for 2026, including Co-Founder and CEO Todd Hodrinsky","Preparing for NIH Phase II SBIR funding and FDA PMA clinical trials as of January 2026"]
Notable Customers
Youngstown Business Incubator (Portfolio Company)
Recent coverage of Nivalon Medical
- Nivalon Medical develops patient-specific, motion-preserving ceramic spinal implant via 3D printing for 2026 clinical use
- Nivalon Medical is redefining spinal care by utilizing AI-driven design and XJet ceramic 3D printing to create the EvoFlex patient-specific implant.
- Nivalon Medical has produced the world's first patient-specific, metal-free ceramic 3D-printed spinal implant.